Many research results indicate the efficacy of mTOR inhibitor monotherapy in some types of cancer; however, preclinical studies demonstrate strong rationales for combinatorial treatment with mTOR inhibitors and other drugs (Hua et al. 2019). Here, MTOR is linked to cancer.